LimmaTech signs license deal with GSK to develop and commercialise Shigella vaccine
With the help of the Wellcome Trust, LimmaTech Bio and GSK have formed a research partnership to create…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jul 23
With the help of the Wellcome Trust, LimmaTech Bio and GSK have formed a research partnership to create…
21 Jul 23
The deal will give $125m to Recludix Pharma in near-term payments from the French pharmaceutical firm in addition…
21 Jul 23
By combining the strengths of both companies, the strategic research collaboration aims to develop more effective and precise…
21 Jul 23
New Pop-Tarts characters are set to appear in upcoming commercials, social content, and brand events, all aimed at…
21 Jul 23
Two iconic brands team up to bring nostalgia to family’s homes with an special cookie release and interactive…
21 Jul 23
Combined with the Ion Torrent Genexus Integrated Sequencer, new assays deliver valuable genomic insights in the field of…
21 Jul 23
To shine a light on female athletes, Cracker Jack® is funding sports dreams for nine "I Am Cracker…
21 Jul 23
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana,…
21 Jul 23
Funding Will Support the Re-Engagement of Diagnosed but Untreated People Living with HCV and HBV in the United…
21 Jul 23
Nestlé has introduced a versatile and cost-effective sugar reduction technology that can be applied across different product categories,…